Back
Smurfit WestRock Plc Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
43
SW
Smurfit WestRock Plc
Last Price:
$37.82
Seasonality Move:
0.37%
Sell
39
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$34.13
Seasonality Move:
6.21%
Sell
43
Smurfit WestRock Plc (SW)
is a Sell
Is Smurfit WestRock Plc a Buy, Sell or Hold?
-
The current Smurfit WestRock Plc [SW] share price is $37.69. The Score for SW is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $34.34. The Score for RARE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SW Stock Price Chart
What is Smurfit WestRock Plc's stock price today?
-
The Smurfit WestRock Plc share price today is $37.69The current trend is relatively stagnant and SW is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $34.34The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
SW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 56.56 | Buy |
| Chaikin Money Flow: | 3976065 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.07 - 36.85) | Buy |
| Bollinger Bands (100): | (36.85 - 45.35) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 48.76 | Sell |
| Chaikin Money Flow: | -1295237 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Buy |
| Bollinger Bands (100): | (28.94 - 34.1) | Buy |
SW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.88 | Buy |
| 20-day SMA: | 35.59 | Buy |
| 50-day SMA: | 37.78 | Sell |
| 200-day SMA: | 42.55 | Sell |
| 8-day EMA: | 36.99 | Buy |
| 20-day EMA: | 36.44 | Buy |
| 50-day EMA: | 37.74 | Sell |
| 200-day EMA: | 42.44 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.02 | Sell |
| 20-day SMA: | 34.61 | Sell |
| 50-day SMA: | 33.59 | Buy |
| 200-day SMA: | 33.68 | Buy |
| 8-day EMA: | 35.6 | Sell |
| 20-day EMA: | 34.92 | Sell |
| 50-day EMA: | 33.67 | Buy |
| 200-day EMA: | 34.81 | Sell |
Smurfit WestRock Plc Earnings Growth & SW Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.79 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Smurfit WestRock Plc Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||